Mitochondrial flavoprotein (MFP)

Mitochondrial flavoproteins are a diverse group of enzymes located within the mitochondria that utilize flavin adenine dinucleotide (FAD) or flavin mononucleotide (FMN) as essential cofactors for electron transfer. They play a critical role in energy metabolism, specifically within the Krebs cycle, the fatty acid beta-oxidation pathway, and the electron transport chain (Complex I and Complex II), where they facilitate the production of ATP through oxidative phosphorylation (StatPearls, 2023). Dysregulation or genetic mutations in these proteins are linked to a variety of metabolic disorders, such as glutaric acidemia type II, and are increasingly studied as targets in oncology and neurodegeneration due to their role in cellular redox balance (UniProt, 2024). Therapeutic interventions include the use of metabolic inhibitors to slow cancer progression or cofactor supplementation to bypass enzymatic blocks in mitochondrial diseases (PubMed, 2022). Because this term describes a broad functional class rather than a single molecular entity, it is often considered too non-specific for precise drug labeling without identifying a specific complex or enzyme.

Other names

Mitochondrial flavoenzymeFAD-dependent mitochondrial enzymeFMN-dependent mitochondrial enzymeFlavin-containing mitochondrial protein

Drugs targeting these proteins typically act by inhibiting specific complexes of the electron transport chain (e.g., Complex I inhibition by metformin) to alter metabolic flux, or by providing cofactor supplementation (e.g., riboflavin) to restore enzymatic activity in genetic deficiencies.